DeepVerge PLC
("DeepVerge" or "Company")
Extension of Broker Offer to 430 p.m. on Monday 31 October
DeepVerge, the environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins, announces that further to the notifications of 27 October 2022 and 28 October 2022 the Broker Offer has been extended, following agreement between the Company and Turner Pope, to 4.30 p.m. on Monday 31 October.
To subscribe for Broker Offer Shares, Existing Shareholders or other interested parties who wish to register their interest in participating in the Broker Offer should click on the following link: DeepVerge - TPI Broker Offer (URL: https://forms.office.com/r/nptcgkst65).
A further announcement will be made following the close of the Broker Offer.
Terms and definitions in this notification are as defined in the notification of 27 October 2022.
For further information, please contact:
DeepVerge plc | Ross Andrews, Chairman | +44 (0) 1904 40 4036
|
| | |
SPARK Advisory Partners Limited (Nominated Adviser) | Neil Baldwin | +44 (0) 113 370 8974 |
| | |
Turner Pope Investments (TPI) Limited (Broker) | Andy Thacker/James Pope | +44 (0) 20 3657 0050 |
Market Abuse Regulation (MAR) Disclosure
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.